KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,433,048 | -3.0% | 705,378 | +12.5% | 0.00% | 0.0% |
| Q2 2023 | $6,632,454 | -14.4% | 626,886 | -1.0% | 0.00% | -50.0% |
| Q1 2023 | $7,744,060 | -18.0% | 633,202 | -16.8% | 0.00% | 0.0% |
| Q4 2022 | $9,446,914 | +8.6% | 761,234 | +19.5% | 0.00% | 0.0% |
| Q3 2022 | $8,698,000 | -25.1% | 636,812 | +0.5% | 0.00% | 0.0% |
| Q2 2022 | $11,617,000 | +10.5% | 633,782 | -3.0% | 0.00% | 0.0% |
| Q1 2022 | $10,509,000 | +13.6% | 653,548 | -1.1% | 0.00% | 0.0% |
| Q4 2021 | $9,252,000 | -34.1% | 660,861 | -11.8% | 0.00% | 0.0% |
| Q3 2021 | $14,039,000 | -12.0% | 749,534 | -2.0% | 0.00% | -33.3% |
| Q2 2021 | $15,954,000 | -21.2% | 765,179 | +6.8% | 0.00% | -25.0% |
| Q1 2021 | $20,253,000 | -17.5% | 716,413 | -4.6% | 0.00% | -20.0% |
| Q4 2020 | $24,536,000 | +18.4% | 751,263 | +11.1% | 0.01% | 0.0% |
| Q3 2020 | $20,719,000 | +81.3% | 676,175 | -3.5% | 0.01% | +66.7% |
| Q2 2020 | $11,425,000 | +151.5% | 700,917 | +53.5% | 0.00% | +200.0% |
| Q1 2020 | $4,543,000 | -23.7% | 456,615 | +5.5% | 0.00% | 0.0% |
| Q4 2019 | $5,953,000 | -15.7% | 432,980 | -7.0% | 0.00% | -50.0% |
| Q3 2019 | $7,063,000 | -7.0% | 465,615 | +20.8% | 0.00% | 0.0% |
| Q2 2019 | $7,591,000 | +21.0% | 385,478 | +1.9% | 0.00% | 0.0% |
| Q1 2019 | $6,275,000 | +19.1% | 378,229 | +0.8% | 0.00% | +100.0% |
| Q4 2018 | $5,269,000 | -20.2% | 375,255 | -0.5% | 0.00% | -50.0% |
| Q3 2018 | $6,603,000 | +13.6% | 377,317 | +18.1% | 0.00% | +100.0% |
| Q2 2018 | $5,813,000 | +21.3% | 319,420 | +25.0% | 0.00% | 0.0% |
| Q1 2018 | $4,791,000 | +33.5% | 255,508 | +8.9% | 0.00% | 0.0% |
| Q4 2017 | $3,589,000 | +14.4% | 234,547 | +11.8% | 0.00% | 0.0% |
| Q3 2017 | $3,137,000 | +128.6% | 209,879 | +42.3% | 0.00% | – |
| Q2 2017 | $1,372,000 | +997.6% | 147,483 | +939.3% | 0.00% | – |
| Q1 2017 | $125,000 | +71.2% | 14,190 | +14.6% | 0.00% | – |
| Q4 2016 | $73,000 | +7.4% | 12,382 | +13.7% | 0.00% | – |
| Q3 2016 | $68,000 | – | 10,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |